R. Nayar
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 2
-
- Hematopoietic Stem Cell Transplantation 4
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- D. Robert Sutherland (8 shared papers)Armand Keating (4 shared papers)Alexander K. Stewart (1 shared paper)Monica Doedens (2 shared papers)A. Keith Stewart (2 shared papers)Connie J. Eaves (2 shared papers)Mark D. Minden (2 shared papers)JD Cashman (2 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Pediatric Blood & Cancer (1 paper)Clinical Immunology Newsletter (1 paper)
- Partner nations
- CanadaItalyUnited States
In The Last Decade
R. Nayar
14 papers receiving 571 citations
Peers
Comparison fields: 5 of 58
- Hematology 313
- Genetics 122
- Oncology 154
- Immunology 116
- Cancer Research 62
Countries citing papers authored by R. Nayar
This map shows the geographic impact of R. Nayar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Nayar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Nayar more than expected).
Fields of papers citing papers by R. Nayar
This network shows the impact of papers produced by R. Nayar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Nayar. The network helps show where R. Nayar may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Nayar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. | 1994 | 173 |
| 2 | 1998 | 162 | |
| 3 | 2006 | 90 | |
| 4 | Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep. | 1996 | 50 |
| 5 | Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections. | 1995 | 40 |
| 6 | 1997 | 18 | |
| 7 | 1997 | 17 | |
| 8 | 2011 | 13 | |
| 9 | Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors. | 1994 | 9 |
| 10 | 1996 | 8 | |
| 11 | 1998 | 7 | |
| 12 | 2004 | 6 | |
| 13 | 2004 | 2 | |
| 14 | 2004 | 1 |
About R. Nayar
R. Nayar is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 596 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers), Neonatal Respiratory Health Research (2 papers), Estrogen and related hormone effects (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Hematology (313 citations), Genetics (122 citations), Oncology (154 citations), Immunology (116 citations) and Cancer Research (62 citations). R. Nayar has collaborated with scholars based in Canada, Italy and United States. Frequent co-authors include D. Robert Sutherland, Armand Keating, Alexander K. Stewart, Monica Doedens, A. Keith Stewart, Connie J. Eaves, Mark D. Minden, JD Cashman, Tsvee Lapidot and Jean Wang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Pediatric Blood & Cancer and Clinical Immunology Newsletter.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.